Manayan Regan C, Ladd-Luthringshauser Olivia H, Packer Alison, Tribulski Kathryn, Winans Audrey, Vecchiotti Mark A, Scott Andrew R
Tufts University School of Medicine, Boston, MA, United States of America.
University of Massachusetts Medical School, Worcester, MA, United States of America; Division of Pediatric Otolaryngology and Facial Plastic Surgery, Tufts Children's Hospital, Boston, MA, United States of America.
Am J Otolaryngol. 2022 Jan-Feb;43(1):103223. doi: 10.1016/j.amjoto.2021.103223. Epub 2021 Sep 11.
To determine if hearScreen®, a smartphone-based pure tone audiometric screen, serves as an effective hearing screen for identifying hearing loss in children at risk, such as those with chronic otitis media and/or craniofacial anomalies.
A cross-sectional, single-center, prospective study at an urban tertiary care hospital was completed. From June to October 2019, a total of 208 pediatric ears at risk for hearing loss were evaluated by both hearScreen® and conventional pure tone audiometry. The efficacy of hearScreen® for detecting hearing loss in a pediatric population at risk was determined.
A total of 208 pediatric ears at risk for hearing loss were screened. HearScreen® demonstrated a sensitivity of 85%, a specificity of 41%, a positive predictive value of 36%, and a negative predictive value of 87%. Subgroup analysis stratified by hearing loss type showed that hearScreen® screens for conductive hearing loss with increased sensitivity.
This investigation suggests that hearScreen® may serve as a an accessible, low-cost, and sensitive pure tone audiometric screen for hearing loss in children at risk, particularly those with conductive hearing loss, with the caveat that it may generate a high proportion of false positives due to the influence of ambient noise, especially when screening at 500 Hz. Future investigations should weigh the utility of including 500 Hz in the screening protocol as well as assess methods that may mitigate the influence of ambient noise during a pure-tone audiometric screen.
确定基于智能手机的纯音听力筛查应用程序hearScreen®是否可作为一种有效的听力筛查工具，用于识别有听力损失风险的儿童，如患有慢性中耳炎和/或颅面畸形的儿童。
在一家城市三级护理医院完成了一项横断面、单中心、前瞻性研究。2019年6月至10月，共有208只存在听力损失风险的儿科耳朵接受了hearScreen®和传统纯音听力测试评估。确定了hearScreen®在有听力损失风险的儿科人群中检测听力损失的有效性。
共筛查了208只存在听力损失风险的儿科耳朵。hearScreen®的灵敏度为85%，特异度为41%，阳性预测值为36%，阴性预测值为87%。按听力损失类型分层的亚组分析表明，hearScreen®对传导性听力损失的筛查灵敏度更高。
本研究表明，hearScreen®可能是一种可及、低成本且敏感的纯音听力筛查工具，用于筛查有听力损失风险的儿童，尤其是传导性听力损失的儿童，但需注意的是，由于环境噪声的影响，它可能会产生较高比例的假阳性结果，尤其是在500Hz进行筛查时。未来的研究应权衡在筛查方案中纳入500Hz的实用性，以及评估在纯音听力筛查期间可能减轻环境噪声影响的方法。
